Global Gentamicin Sulfate API Market Research Report 2024

Publication ID:

PB506250349

Publication Date:

June 27, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Gentamicin Sulfate(CAS:1405-41-0), a water-soluble antibiotic of the aminoglycoside group, is derived by the growth of Micromonospora purpurea, an actinomycete.
The global Gentamicin Sulfate API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gentamicin Sulfate API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gentamicin Sulfate API.
Report Scope
The Gentamicin Sulfate API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gentamicin Sulfate API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gentamicin Sulfate API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Otto Brandes
Suanfarma
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
FUJIAN FUKANG PHARMACEUTICAL
Sichuan Long March Pharmaceutical
Biotechnica Pharma Global
Sandoz B2B
ACS DOBFAR SPA
Segment by Type
Above 98 %
Above 99 %
Segment by Application
Ointment
Injection
Tablets
Granules
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gentamicin Sulfate API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Gentamicin Sulfate API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Gentamicin Sulfate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Gentamicin Sulfate API Market Overview
1.1 Product Definition
1.2 Gentamicin Sulfate API Segment by Type
1.2.1 Global Gentamicin Sulfate API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Gentamicin Sulfate API Segment by Application
1.3.1 Global Gentamicin Sulfate API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Ointment
1.3.3 Injection
1.3.4 Tablets
1.3.5 Granules
1.3.6 Others
1.4 Global Market Growth Prospects
1.4.1 Global Gentamicin Sulfate API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Gentamicin Sulfate API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Gentamicin Sulfate API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Gentamicin Sulfate API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Gentamicin Sulfate API Production Market Share by Manufacturers (2019-2024)
2.2 Global Gentamicin Sulfate API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Gentamicin Sulfate API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Gentamicin Sulfate API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Gentamicin Sulfate API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Gentamicin Sulfate API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Gentamicin Sulfate API, Product Offered and Application
2.8 Global Key Manufacturers of Gentamicin Sulfate API, Date of Enter into This Industry
2.9 Gentamicin Sulfate API Market Competitive Situation and Trends
2.9.1 Gentamicin Sulfate API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Gentamicin Sulfate API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Gentamicin Sulfate API Production by Region
3.1 Global Gentamicin Sulfate API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Gentamicin Sulfate API Production Value by Region (2019-2030)
3.2.1 Global Gentamicin Sulfate API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Gentamicin Sulfate API by Region (2025-2030)
3.3 Global Gentamicin Sulfate API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Gentamicin Sulfate API Production by Region (2019-2030)
3.4.1 Global Gentamicin Sulfate API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Gentamicin Sulfate API by Region (2025-2030)
3.5 Global Gentamicin Sulfate API Market Price Analysis by Region (2019-2024)
3.6 Global Gentamicin Sulfate API Production and Value, Year-over-Year Growth
3.6.1 North America Gentamicin Sulfate API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Gentamicin Sulfate API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Gentamicin Sulfate API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Gentamicin Sulfate API Production Value Estimates and Forecasts (2019-2030)
4 Gentamicin Sulfate API Consumption by Region
4.1 Global Gentamicin Sulfate API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Gentamicin Sulfate API Consumption by Region (2019-2030)
4.2.1 Global Gentamicin Sulfate API Consumption by Region (2019-2024)
4.2.2 Global Gentamicin Sulfate API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Gentamicin Sulfate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Gentamicin Sulfate API Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Gentamicin Sulfate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Gentamicin Sulfate API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Gentamicin Sulfate API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Gentamicin Sulfate API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Gentamicin Sulfate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Gentamicin Sulfate API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Gentamicin Sulfate API Production by Type (2019-2030)
5.1.1 Global Gentamicin Sulfate API Production by Type (2019-2024)
5.1.2 Global Gentamicin Sulfate API Production by Type (2025-2030)
5.1.3 Global Gentamicin Sulfate API Production Market Share by Type (2019-2030)
5.2 Global Gentamicin Sulfate API Production Value by Type (2019-2030)
5.2.1 Global Gentamicin Sulfate API Production Value by Type (2019-2024)
5.2.2 Global Gentamicin Sulfate API Production Value by Type (2025-2030)
5.2.3 Global Gentamicin Sulfate API Production Value Market Share by Type (2019-2030)
5.3 Global Gentamicin Sulfate API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Gentamicin Sulfate API Production by Application (2019-2030)
6.1.1 Global Gentamicin Sulfate API Production by Application (2019-2024)
6.1.2 Global Gentamicin Sulfate API Production by Application (2025-2030)
6.1.3 Global Gentamicin Sulfate API Production Market Share by Application (2019-2030)
6.2 Global Gentamicin Sulfate API Production Value by Application (2019-2030)
6.2.1 Global Gentamicin Sulfate API Production Value by Application (2019-2024)
6.2.2 Global Gentamicin Sulfate API Production Value by Application (2025-2030)
6.2.3 Global Gentamicin Sulfate API Production Value Market Share by Application (2019-2030)
6.3 Global Gentamicin Sulfate API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Otto Brandes
7.1.1 Otto Brandes Gentamicin Sulfate API Corporation Information
7.1.2 Otto Brandes Gentamicin Sulfate API Product Portfolio
7.1.3 Otto Brandes Gentamicin Sulfate API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Otto Brandes Main Business and Markets Served
7.1.5 Otto Brandes Recent Developments/Updates
7.2 Suanfarma
7.2.1 Suanfarma Gentamicin Sulfate API Corporation Information
7.2.2 Suanfarma Gentamicin Sulfate API Product Portfolio
7.2.3 Suanfarma Gentamicin Sulfate API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Suanfarma Main Business and Markets Served
7.2.5 Suanfarma Recent Developments/Updates
7.3 Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
7.3.1 Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. Gentamicin Sulfate API Corporation Information
7.3.2 Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. Gentamicin Sulfate API Product Portfolio
7.3.3 Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. Gentamicin Sulfate API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. Main Business and Markets Served
7.3.5 Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. Recent Developments/Updates
7.4 FUJIAN FUKANG PHARMACEUTICAL
7.4.1 FUJIAN FUKANG PHARMACEUTICAL Gentamicin Sulfate API Corporation Information
7.4.2 FUJIAN FUKANG PHARMACEUTICAL Gentamicin Sulfate API Product Portfolio
7.4.3 FUJIAN FUKANG PHARMACEUTICAL Gentamicin Sulfate API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 FUJIAN FUKANG PHARMACEUTICAL Main Business and Markets Served
7.4.5 FUJIAN FUKANG PHARMACEUTICAL Recent Developments/Updates
7.5 Sichuan Long March Pharmaceutical
7.5.1 Sichuan Long March Pharmaceutical Gentamicin Sulfate API Corporation Information
7.5.2 Sichuan Long March Pharmaceutical Gentamicin Sulfate API Product Portfolio
7.5.3 Sichuan Long March Pharmaceutical Gentamicin Sulfate API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Sichuan Long March Pharmaceutical Main Business and Markets Served
7.5.5 Sichuan Long March Pharmaceutical Recent Developments/Updates
7.6 Biotechnica Pharma Global
7.6.1 Biotechnica Pharma Global Gentamicin Sulfate API Corporation Information
7.6.2 Biotechnica Pharma Global Gentamicin Sulfate API Product Portfolio
7.6.3 Biotechnica Pharma Global Gentamicin Sulfate API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Biotechnica Pharma Global Main Business and Markets Served
7.6.5 Biotechnica Pharma Global Recent Developments/Updates
7.7 Sandoz B2B
7.7.1 Sandoz B2B Gentamicin Sulfate API Corporation Information
7.7.2 Sandoz B2B Gentamicin Sulfate API Product Portfolio
7.7.3 Sandoz B2B Gentamicin Sulfate API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Sandoz B2B Main Business and Markets Served
7.7.5 Sandoz B2B Recent Developments/Updates
7.8 ACS DOBFAR SPA
7.8.1 ACS DOBFAR SPA Gentamicin Sulfate API Corporation Information
7.8.2 ACS DOBFAR SPA Gentamicin Sulfate API Product Portfolio
7.8.3 ACS DOBFAR SPA Gentamicin Sulfate API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 ACS DOBFAR SPA Main Business and Markets Served
7.7.5 ACS DOBFAR SPA Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Gentamicin Sulfate API Industry Chain Analysis
8.2 Gentamicin Sulfate API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Gentamicin Sulfate API Production Mode & Process
8.4 Gentamicin Sulfate API Sales and Marketing
8.4.1 Gentamicin Sulfate API Sales Channels
8.4.2 Gentamicin Sulfate API Distributors
8.5 Gentamicin Sulfate API Customers
9 Gentamicin Sulfate API Market Dynamics
9.1 Gentamicin Sulfate API Industry Trends
9.2 Gentamicin Sulfate API Market Drivers
9.3 Gentamicin Sulfate API Market Challenges
9.4 Gentamicin Sulfate API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Otto Brandes
Suanfarma
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
FUJIAN FUKANG PHARMACEUTICAL
Sichuan Long March Pharmaceutical
Biotechnica Pharma Global
Sandoz B2B
ACS DOBFAR SPA

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂